According to SPER Market Research, the Custom Antibody Market estimated to reach USD 889.6 million by 2030 with a CAGR of 9.4%.
Increasing industry-academia collaborations, growing research activities and funding, quality concerns over catalogue antibodies, growing research activity particularly in the life sciences industry, rising focus on therapeutic antibodies and extensive pipeline drugs; are the key factors that act as the fuel for the escalation of the market.
Antibody development is a costly and time consuming process, availability of alternative antibodies in the market that is a challenge to the custom antibody market expansion.
Growing demand for personalized medicine in protein therapeutics, rising focus on biomarker discovery, high growth opportunities in developing countries.
The antibody development segment, the monoclonal antibody, the mice, the oncology, the pharmaceutical and biopharmaceutical companies segment from service segment, type segment, source segment, research area segment, and end user segment respectively dominated the biggest share of the Custom Antibody Market.
North America owns the biggest share of the Global Custom Antibody Market; this is because of increasing research in the fields of genomics and proteomics, antibody-based therapeutics. The growing investments in the development of structure-based drug designs, and growing demand for high-quality research tools for data reproducibility.
The global Custom Antibody Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; BioLegend, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., GenScript, Merck Group, Rockland Immunochemicals, Thermo Fisher Scientific, Inc.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for Type segment- Monoclonal Antibodies, Other Custom Antibodies, Polyclonal Antibodies, Recombinant Antibodies, for Service segment- Antibody Development, Antibody Production & Purification, and Antibody Fragmentation & Labeling, for Source segment- Mice, Rabbits, for Research-Area segment- Cardiovascular Disease, Immunology, Infectious Diseases, Neurobiology, Oncology, Other Research Areas, Stem Cells, for End-User segment- Academic & Research Institutes, Contract Research organizations, Pharmaceutical & Biotechnology Companies.
This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.